MSA Safety rporated(MSA)
Search documents
Newest firefighter turnout jacket now available to order from Globe Manufacturing Company
Prnewswire· 2025-10-15 12:34
Core Insights - Globe Manufacturing Company has launched the Globe G-XTREME PRO Jacket, designed to meet the evolving needs of firefighters with innovative features and improved comfort [1][2]. Product Features - The jacket features a unique three-panel design with a mesh liner to reduce bulk and enhance mobility [2][3]. - It incorporates AXTION Back and AXTION Sleeve features for additional length and improved reach, combined with Kevlar mesh channels for enhanced mobility [3][6]. - The jacket is certified to meet NFPA 1971, 2018 Edition and NFPA 1970(1971), 2025 Edition standards, ensuring compliance with safety regulations [2]. Fit and Comfort - The redesigned collar fits comfortably with helmets and breathing apparatus, and folds out of the way when not in use [6]. - A broader range of fit options is available, accommodating various body types with sizes ranging from 28 inches to 60 inches in chest size and 26 inches to 40 inches in hem length [6]. Company Background - Globe Manufacturing Company, a subsidiary of MSA Safety, has over 130 years of experience in providing high-quality turnout gear for firefighters [5]. - MSA Safety, headquartered in Cranberry Township, Pennsylvania, reported revenues of $1.8 billion in 2024 and employs over 5,000 associates globally [5].
MSA Safety Schedules Third Quarter 2025 Earnings Conference Call
Prnewswire· 2025-10-14 20:30
Core Viewpoint - MSA Safety Incorporated will host its third quarter 2025 earnings conference call on October 29, 2025, at 10:00 a.m. Eastern Time, with a press release detailing financial results to be issued on October 28, 2025, after market close [1][3]. Company Overview - MSA Safety Incorporated is a global leader in advanced safety products and solutions, with a mission focused on safety innovation since 1914 [3]. - The company reported revenues of $1.8 billion for the year 2024 and is headquartered in Cranberry Township, Pennsylvania, employing over 5,000 associates across more than 40 international locations [3]. Conference Call Details - The earnings call will be available via webcast and can be accessed through the company's investor relations website [2]. - Investors can join the call by dialing a toll-free number or an international number shortly before the start time [3]. - A replay of the conference call will be available for 90 days following the event [2].
Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson's Disease and Movement Disorders
Globenewswire· 2025-10-09 11:25
Core Insights - Alterity Therapeutics announced positive results from the ATH434-201 Phase 2 clinical trial for Multiple System Atrophy (MSA), demonstrating that ATH434 slows disease progression and stabilizes orthostatic hypotension [1][2] Group 1: Clinical Trial Results - The ATH434-201 trial involved 77 participants, comparing two doses of ATH434 (50 mg and 75 mg) against a placebo, with results indicating a 48% relative treatment effect at the 50 mg dose and a 30% effect at the 75 mg dose on the UMSARS I scale at 52 weeks [3][13] - A new analysis accounting for baseline differences in orthostatic hypotension (OH) showed a strengthened efficacy signal in the 75 mg group, with a relative treatment effect of 35% [5][13] - ATH434 demonstrated a beneficial effect on OH symptoms, with placebo patients worsening significantly while both treatment groups remained stable [5][7] Group 2: Neuroimaging and Biomarkers - The trial utilized advanced neuroimaging and biomarkers to refine MSA diagnosis and track disease evolution, showing that ATH434 reduced iron accumulation in affected brain regions [7][8] - Imaging biomarkers supported MSA diagnosis in 96.1% of participants, indicating a multimodal approach may enhance diagnostic accuracy [8][9] Group 3: Safety and Tolerability - ATH434 was well tolerated, with adverse event rates similar to placebo and no serious adverse events attributed to the drug [7][13] - The study also indicated increased outpatient activity levels in participants treated with ATH434, as measured by wearable sensors [7][13] Group 4: Company Overview - Alterity Therapeutics is focused on developing disease-modifying therapies for neurodegenerative diseases, with ATH434 being a lead candidate showing robust clinical efficacy in MSA [11][15] - The company has received Fast Track Designation and Orphan Drug Designation from the FDA for ATH434, highlighting its potential in treating MSA [11][15]
MSA Safety: A Deteriorating Setup (NYSE:MSA)
Seeking Alpha· 2025-09-25 18:50
Core Insights - MSA Safety Incorporated is focusing on enhancing its safety measures, indicating a strategic shift towards greater security in its operations [1] Group 1: Company Overview - MSA Safety Incorporated is identified as a premium safety manufacturer, suggesting a strong market position within the safety equipment industry [1] - The company has experienced a reduction in the premium previously associated with its shares, which may reflect market adjustments or changes in investor sentiment [1] Group 2: Investment Opportunities - The investing group "Value In Corporate Events" provides members with insights into major corporate events such as IPOs, mergers & acquisitions, and earnings reports, aiming to identify the best investment opportunities [1] - The service covers approximately 10 major events each month, indicating a robust framework for tracking significant market movements and potential investment avenues [1]
Pinnacle Is the No. 1 Bank in the Nashville MSA by Deposits for the Eighth Consecutive Year, Holds No.
Businesswire· 2025-09-25 18:00
Core Insights - Pinnacle Financial Partners is the largest bank in the Nashville MSA by deposits for the eighth consecutive year, holding $21.34 billion in local deposits, which is 21.72% of the total market and over 64% more than its closest competitor [1][2][18] - The firm also ranks No. 2 in Tennessee with a 12.94% market share, having grown its share in the past 12 months, indicating strong local trust and preference [2][3] - Pinnacle's growth is attributed to its ability to attract and retain top banking talent, with significant investments in personnel leading to deposit growth nine times the industry average during the current rate cycle [4][19] Market Performance - Pinnacle grew deposits in 23 out of 27 MSAs measured by the FDIC, with eight markets experiencing double-digit growth and three markets triple-digit growth [3][4] - The firm added more deposit dollars than any other bank in the Nashville market over the past year, showcasing its competitive edge [1][2] - In Tennessee, Pinnacle was the biggest deposit grower, demonstrating its effectiveness in expanding market share [2][3] Strategic Initiatives - The recent merger agreement with Synovus is expected to enhance Pinnacle's growth trajectory, combining similar cultures and operational excellence [4][25] - Pinnacle hired 161 revenue-producing associates in 2024 and an additional 71 in the first half of 2025, which is a key driver of its growth model [4][19] - The firm has been recognized as one of America's Best Banks to Work For, reinforcing its reputation as an employer of choice in the financial services sector [18][24]
Mineros S.A. Completes Acquisition of La Pepa Project, Securing 100% Ownership and Advancing Growth Strategy in Chile
Businesswire· 2025-09-22 21:01
Core Insights - Mineros S.A. has completed the acquisition of the remaining 80% interest in the La Pepa Project from Pan American Silver Corp. for approximately US$40 million [1] - With this acquisition, Mineros now holds 100% ownership of the La Pepa Project, which is an advanced gold exploration asset [1] - The La Pepa Project is considered a significant exploration-stage asset with a substantial estimate [1]
MSA Safety Debuts Two New Safety Solutions at National Safety Congress
Prnewswire· 2025-09-15 12:35
Core Insights - MSA Safety, Inc. is focused on responding to the needs of workers by providing innovative equipment [1] Group 1 - The introduction of a new Type II Full Brim Helmet and a Pumped Multigas Detector highlights the company's commitment to worker safety [1]
5 Dividend Aristocrats Where Analysts See Capital Gains
Nasdaq· 2025-09-15 10:13
Core Viewpoint - To be classified as a "Dividend Aristocrat," a company must consistently increase dividends for at least 20 consecutive years, attracting significant investor interest and demand for shares [1] Group 1: Dividend Growth Stocks - The SPDR S&P Dividend ETF has identified five dividend growth stocks with substantial upside potential compared to average analyst target prices over the next 12 months [2] - The identified stocks are MDU Resources Group Inc, VF Corp, Polaris Inc, Colgate-Palmolive Co, and MSA Safety Inc, each showing a notable percentage upside to their analyst targets [3][4] Group 2: Analyst Target Prices and Returns - MDU Resources Group Inc has a recent price of $25.76, with an average analyst target of $35.50, indicating a 37.81% upside potential [4] - VF Corp has a recent price of $57.49, with a target of $77.85, showing a 35.41% upside [4] - Polaris Inc's recent price is $110.26, with a target of $143.67, reflecting a 30.30% upside [4] - Colgate-Palmolive Co has a recent price of $72.20, with a target of $88.10, indicating a 22.02% upside [4] - MSA Safety Inc has a recent price of $136.62, with a target of $166.00, showing a 21.50% upside [4] - The expected total return for these stocks combines share price upside and dividend yield, with MDU Resources Group Inc showing a total return potential of 41.19% [4] Group 3: Dividend Growth Rates - MDU Resources Group Inc's trailing twelve months (TTM) dividend increased from $0.842 to $0.862, reflecting a growth of 2.38% [5] - VF Corp's TTM dividend grew from $1.94 to $1.98, a growth of 2.06% [5] - Polaris Inc's TTM dividend increased from $2.49 to $2.53, showing a growth of 1.61% [5] - Colgate-Palmolive Co's TTM dividend rose from $1.76 to $1.80, reflecting a growth of 2.27% [5] - MSA Safety Inc's TTM dividend increased from $1.72 to $1.76, showing a growth of 2.33% [5]
Tiziana Life Sciences doses first MSA patient in new trial – ICYMI
Proactiveinvestors NA· 2025-08-15 20:36
Company Overview - Proactive is a publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team operates from key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] Market Focus - The company specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - Proactive delivers news and insights across various sectors including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
Tiziana Life Sciences doses first patient in Phase 2a MSA trial
Proactiveinvestors NA· 2025-08-14 13:44
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The news team covers medium and small-cap markets, as well as blue-chip companies, commodities, and broader investment stories [3] - Proactive's content includes insights across various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - Proactive is committed to adopting technology to enhance workflows and content production [4] - The company utilizes automation and software tools, including generative AI, while ensuring all content is edited and authored by humans [5]